A randomized phase III study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer (JACCRO GC-07 trial).

Author:

Kodera Yasuhiro1,Yoshida Kazuhiro2,Kochi Mitsugu3,Ichikawa Wataru4,Kakeji Yoshihiro5,Sano Takeshi6,Nagao Narutoshi7,Takahashi Masazumi8,Takagane Akinori9,Nakamura Masanori10,Kaji Masahide11,Okitsu Hiroshi12,Nomura Takashi13,Matsui Takanori14,Yoshikawa Takaki15,Matsuyama Jin16,Yamada Makoto17,Ito Yuichi18,Takeuchi Masahiro19,Fujii Masashi20

Affiliation:

1. Nagoya University, Nagoya, Japan;

2. Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, Japan;

3. Department of Digestive Surgery, Nihon University Itabashi Hospital, Tokyo, Japan;

4. Division of Medical Oncology, Showa University Fujigaoka Hospital, Yokohama, Japan;

5. Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan;

6. Japanese Foundation for Cancer Research Cancer Institute Hospital, Tokyo, Japan;

7. Department of Surgery, Gifu Prefectural General Medical Center, Gifu, Japan;

8. Division of Gastroenterological Surgery, Yokohama Municipal Citizen's Hospital, Yokohama, Japan;

9. Hakodate Goryoukaku Hospital, Hakodate, Japan;

10. Department of Surgery, Konan Kosei Hospital, Konan, Japan;

11. Toyama Prefectural Central Hospital, Toyama, Japan;

12. Department of Surgery, Tokushima Red Cross Hospital, Komatsushima, Japan;

13. Department of Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan;

14. Department of Gastrointestinal Surgery, Aichi Cancer Center Aichi Hospital, Okazaki, Japan;

15. Kanagawa Cancer Center, Kanagawa, Japan;

16. Department of Surgery, Yao Municipal Hospital, Yao, Japan;

17. Department of Surgery, Gifu Municipal Hospital, Gifu, Japan;

18. Aichi Cancer Center Hospital, Aichi, Japan;

19. Department of Clinical Medicine (Biostatistics), School of Pharmacy, Kitasato University, Tokyo, Japan;

20. Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3